Global Cancer Diagnostics Market Research Report 2017 Key Players Analysis and Forecast to 2022

Executive Summary

Rising incidences of cancer owing to unhealthy food habits and sedentary lifestyle coupled with the growing technological advancements has resulted in the growth of global cancer diagnostics market
Market for cancer diagnostics is growing at a steady pace due to higher incidences of cancer among the population, where emerging markets are expected to achieve higher growth.

Given the growing demand for early detection of cancer, tumor marker tests are gaining prominence and are projected to witness stronger growth in the coming years.

Growth in the incidences of cancer across the globe is due to the sedentary lifestyle such as increasing tobacco consumption and unhealthy eating habits.

Advancement in genomics has resulted in the growing cancer research, due to which early detection of cancer is gaining popularity.

Global Cancer Diagnostics Market is forecasted to grow at a CAGR of 8.8% during 2016 – 2021F, on account of rising incidences of cancer globally, along with the increasing technological advancement driven by focus on cancer research

North America region remains the major market followed by Europe in the actual period. In the forecast period, APAC region will witness strong growth driven by countries such as India and China.

According to Researcher’s research report, Global Cancer Diagnostics Market: Trends, Opportunities and Forecasts (2016-2021), Global Cancer Diagnostics market is projected to exhibit a CAGR of over ~8.8% during 2016 - 2021. On the basis of market segment, Global Cancer Diagnostics Market has been segmented by type (By Type: Imaging Tests, Endoscopy, Biopsy and Tumor Marker, By Imaging Tests Sub-Type: MRI, Ultrasound, PET-CT Scan, Mammography, By Region: North America, Latin America, APAC, Europe and MEA.)

Request a sample report @ https://www.wiseguyreports.com/sample-request/822734-global-cancer-diagnostics-market-apac-europe-mea

Scope of the Report

The report provides Segmentation by Type

•Imaging Tests
•Endoscopy
•Biopsy
•Tumor Marker

The report provides Segmentation by Sub- Type

•Imaging Tests : MRI, Ultrasound, PET-CT Scan, Mammography

The report provides coverage by Region

•North America
•Europe
•Asia Pacific
•Latin America
•Middle East and Africa (MEA)

Customization of the Report

The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.

Complete report details @ https://www.wiseguyreports.com/reports/822734-global-cancer-diagnostics-market-apac-europe-mea

Table of Content

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

3.1. North America and Europe to drive the Cancer Diagnostic Market
3.2. Lung, Breast, Bowel and Prostrate Cancers to remain the major cause of Cancer Diagnostics
3.3. Cancer Imaging Test would form the largest market segment for Cancer Diagnosis

4. Global Cancer Diagnostics Market: An Overview

4.1. Product Overview
4.1.1.Global Cancer Diagnostics Market, By Value 2011-2015
4.1.2.Global Cancer Diagnostics Market, By Value 2016-2021F
Global Cancer Diagnostics Market: By Type (Imaging Tests, Endoscopy, Biopsy, Tumour Marker Tests)
4.1. Global Imaging Tests Market
4.1.1.By Value (Historic 2011-15)
4.1.2.By Value (Forecast 2016E-2021F)
4.1.3.By Sub-Type - Ultrasound, PET-CT Scan, Mammography, MRI (By Value 2016E-2021F)
4.2. Global Endoscopy Cancer Diagnostics Market
4.2.1.By Value (Historic 2011-15)
4.2.2.By Value (Forecast 2016E-2021F)
4.3. Global Biopsy Market
4.3.1.By Value (Historic 2011-15)
4.3.2.By Value (Forecast 2016E-2021F)
4.4. Global Tumour Marker Tests Market
4.4.1.By Value (Historic 2011-15)
4.4.2.By Value (Forecast 2016E-2021F)
4.5. Global Imaging Test Market, By Region, By Value (2016E-2021F)

5. North America Cancer Diagnostics Market: An Overview

5.1. North America Cancer Diagnostics Market
5.1.1.By Value (Historic 2011-15)
5.1.2.By Value (Forecast 2016E-2021F)
5.2. North America Cancer Diagnostics Country Overview – USA, Canada

6. APAC Cancer Diagnostics Market: An Overview

6.1. APAC Cancer Diagnostics Market
6.1.1.By Value (Historic 2011-15)
6.1.2.By Value (Forecast 2016E-2021F)
6.2. APAC Cancer Diagnostics Country Overview – India, China

7. Europe Cancer Diagnostics Market: An Overview

7.1. Europe Cancer Diagnostics Market
7.1.1.By Value (Historic 2011-15)
7.1.2.By Value (Forecast 2016E-2021F)
7.2. Europe Cancer Diagnostics Country Overview –Denmark, UK

8. Latin America Cancer Diagnostics Market: An Overview

8.1. Latin America Cancer Diagnostics Market
8.1.1.By Value (Historic 2011-15)
8.1.2.By Value (Forecast 2016E-2021F)
8.2. Latin America Cancer Diagnostics Country Overview – Chile, Brazil

9. MEA Cancer Diagnostics Market: An Overview

9.1. MEA Cancer Diagnostics Market
9.1.1.By Value (Historic 2011-15)
9.1.2.By Value (Forecast 2016E-2021F)
9.2. MEA Cancer Diagnostics Country Overview – UAE

10. Market Dynamics

10.1. Market Trends & Developments
10.2. Market Drivers
10.3. Challenges

11. Policy Regulations

12. SWOT Analysis

13. Porter Five Force Model

14. Company Profiling

14.1. Abbott Laboratories
14.2. Becton Dickinson and Company
14.3. F. Hoffmann-La Roche AG (Roche Diagnostics)
14.4. General Electric Co (General Healthcare)
14.5. Thermo Fisher Scientific
14.6. Agilent Technologies, Inc.
14.7. Illumina, Inc.
14.8. Hologic Inc.
14.9. C. R. Bard Inc.

15 About us & DisclaimerList of Figures

Purchase Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=822734

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Contact US:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

This release was published on openPR.